{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:32:55Z","timestamp":1787563975557,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Giggle incontinence is a bladder storage disorder characterized by uncontrolled voiding during or immediately after laughter. Many children are refractory to available therapies or experience considerable side-effects. This study aimed to determine the efficacy of intravesical Botox injections in the management of giggle incontinence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective review of all children who received 200iU intravesical\n                      <jats:italic>botulinum toxin-A<\/jats:italic>\n                      for giggle incontinence over twelve years was performed. All children experienced complete bladder emptying during or immediately after laughter as their primary complaint, with or without a related voiding disorder. Outcomes were characterised as: \u201cno response\u201d (0\u201349% reduction), \u201cpartial response\u201d (50\u201399% reduction), or \u201ccomplete response\u201d (100% reduction).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total 34 procedures (range: 1\u20135) in 17 children were included. Median age at first treatment was 11 years (range: 6-17y). Complete response occurred in 65% of patients and partial response in 18%. Of those who experienced complete response, 55% (6\/11) had no relapse of symptoms with a median duration of follow-up of 5 years (IQR 3.5-6.5y).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Giggle incontinence is a rare but significant condition with marked impact on quality of life. This is the first study describing the use of intravesical Botox injection in this population, demonstrating safety and efficacy with a sustained response to treatment in many patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00383-026-06297-7","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:15:15Z","timestamp":1771420515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intravesical botox as an effective therapy for giggle incontinence in children"],"prefix":"10.1007","volume":"42","author":[{"given":"Eliza","family":"Szwarcberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kimber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Taghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"issue":"7","key":"6297_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41390-024-03065-y","volume":"95","author":"AA Gonz\u00e1lez-Maldonado","year":"2024","unstructured":"Gonz\u00e1lez-Maldonado AA, Garc\u00eda-M\u00e9rida M (2024) Giggle incontinence: a scoping review. Pediatr Res 95(7):1720\u20131725. https:\/\/doi.org\/10.1038\/s41390-024-03065-y","journal-title":"Pediatr Res"},{"issue":"7","key":"6297_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00120-007-1333-6","volume":"46","author":"B Wefer","year":"2007","unstructured":"Wefer B, Seif C, van der Horst C, J\u00fcnemann KP, Braun PM (2007) [Botulinum toxin a injection for treatment-refractory giggle incontinence]. Urologe A 46(7):773\u20135. https:\/\/doi.org\/10.1007\/s00120-007-1333-6","journal-title":"Urologe A"},{"issue":"1","key":"6297_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00383-025-06106-7","volume":"41","author":"E Szwarcberg","year":"2025","unstructured":"Szwarcberg E, Kimber C, Taghavi K (2025) Safety of 200iU of intravesical Botox in children of all ages with functional urinary incontinence. Pediatr Surg Int 41(1):204. https:\/\/doi.org\/10.1007\/s00383-025-06106-7","journal-title":"Pediatr Surg Int"},{"issue":"4","key":"6297_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin PF, Bauer SB, Bower W et al (2016) The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international children\u2019s continence society. Neurourol Urodyn Apr 35(4):471\u2013481. https:\/\/doi.org\/10.1002\/nau.22751","journal-title":"Neurourol Urodyn Apr"},{"issue":"5","key":"6297_CR5","doi-asserted-by":"publisher","first-page":"646.e1","DOI":"10.1016\/j.jpurol.2021.07.015","volume":"17","author":"A Hac\u0131islamo\u011flu","year":"2021","unstructured":"Hac\u0131islamo\u011flu A, Ek\u015fi M, \u00d6zl\u00fc DN et al (2021) Evaluation of the efficacies of methylphenidate and biofeedback treatments in giggle incontinence: one-year follow-up study. J Pediatr Urol 17(5):646.e1-646.e5. https:\/\/doi.org\/10.1016\/j.jpurol.2021.07.015","journal-title":"J Pediatr Urol"},{"issue":"5","key":"6297_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jpurol.2017.04.021","volume":"13","author":"BL Logan","year":"2017","unstructured":"Logan BL, Blais S (2017) Giggle incontinence: evolution of concept and treatment. J Pediatr Urol 13(5):430\u2013435. https:\/\/doi.org\/10.1016\/j.jpurol.2017.04.021","journal-title":"J Pediatr Urol"},{"issue":"6","key":"6297_CR7","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/nau.24725","volume":"40","author":"S Mohan Kunnath","year":"2021","unstructured":"Mohan Kunnath S, Clothier J, Solomon E, Wright AJ, Taghizadeh A (2021) Urodynamic characterization of giggle incontinence in children. Neurourol Urodyn 40(6):1600\u20131608. https:\/\/doi.org\/10.1002\/nau.24725","journal-title":"Neurourol Urodyn"},{"issue":"4 Suppl","key":"6297_CR8","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.juro.2009.03.021","volume":"182","author":"I Richardson","year":"2009","unstructured":"Richardson I, Palmer LS (2009) Successful treatment for giggle incontinence with biofeedback. J Urol 182(4 Suppl):2062\u20136. https:\/\/doi.org\/10.1016\/j.juro.2009.03.021","journal-title":"J Urol"},{"issue":"7","key":"6297_CR9","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/nau.21046","volume":"30","author":"JH Chang","year":"2011","unstructured":"Chang JH, Lee KY, Kim TB, Yoon SJ, Lee T, Kim KH (2011) Clinical and urodynamic effect of methylphenidate for the treatment of giggle incontinence (enuresis risoria). Neurourol Urodyn 30(7):1338\u201342. https:\/\/doi.org\/10.1002\/nau.21046","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"6297_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1590\/s1677-5538.Ibju.2014.0560","volume":"42","author":"O Telli","year":"2016","unstructured":"Telli O, Hamidi N, Kayis A, Suer E, Soygur T, Burgu B (2016) Can the success of structured therapy for giggle incontinence be predicted? Int Braz J Urol 42(2):334\u20138. https:\/\/doi.org\/10.1590\/s1677-5538.Ibju.2014.0560","journal-title":"Int Braz J Urol"},{"issue":"2","key":"6297_CR11","doi-asserted-by":"publisher","first-page":"94.e1","DOI":"10.1016\/j.jpurol.2015.06.019","volume":"12","author":"T Greer","year":"2016","unstructured":"Greer T, Abbott J, Breytenbach W, Barker A, Khosa J, Samnakay N (2016) Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children. J Pediatr Urol 12(2):94.e1\u20136. https:\/\/doi.org\/10.1016\/j.jpurol.2015.06.019","journal-title":"J Pediatr Urol"},{"issue":"3","key":"6297_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00383-011-3039-5","volume":"28","author":"DT McDowell","year":"2012","unstructured":"McDowell DT, Noone D, Tareen F, Waldron M, Quinn F (2012) Urinary incontinence in children: botulinum toxin is a safe and effective treatment option. Pediatr Surg Int 28(3):315\u201320. https:\/\/doi.org\/10.1007\/s00383-011-3039-5","journal-title":"Pediatr Surg Int"},{"key":"6297_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-04217-z","author":"NB Hougaard","year":"2024","unstructured":"Hougaard NB, Breinbjerg A, Kamperis K, Skott M (2024) Botulinum neurotoxin type A in paediatric non-neurogenic therapy resistant overactive bladder: a cohort study. Int Urol Nephrol https:\/\/doi.org\/10.1007\/s11255-024-04217-z","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"6297_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s0022-5347(06)00301-6","volume":"176","author":"P Hoebeke","year":"2006","unstructured":"Hoebeke P, De Caestecker K, Vande Walle J et al (2006) The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176(1):328\u2013330. https:\/\/doi.org\/10.1016\/s0022-5347(06)00301-6. (discussion 330-1)","journal-title":"J Urol"},{"issue":"6","key":"6297_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(14)61481-0","volume":"13","author":"V Romikh","year":"2014","unstructured":"Romikh V, Borisenko L (2014) C93: Biofeedback with pelvic floor muscles electrostimulation in treatment of giggle urinary incontinence in young women. Eur Urol Suppl 13(6):e1280. https:\/\/doi.org\/10.1016\/S1569-9056(14)61481-0","journal-title":"Eur Urol Suppl"},{"issue":"2 Pt 2","key":"6297_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/00005392-199608001-00023","volume":"156","author":"PK Sher","year":"1996","unstructured":"Sher PK, Reinberg Y (1996) Successful treatment of giggle incontinence with methylphenidate. J Urol 156(2 Pt 2):656\u20138. https:\/\/doi.org\/10.1097\/00005392-199608001-00023","journal-title":"J Urol"},{"issue":"4 Suppl","key":"6297_CR17","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.juro.2009.04.085","volume":"182","author":"AK Berry","year":"2009","unstructured":"Berry AK, Zderic S, Carr M (2009) Methylphenidate for giggle incontinence. J Urol 182(4 Suppl):2028\u201332. https:\/\/doi.org\/10.1016\/j.juro.2009.04.085","journal-title":"J Urol"},{"issue":"2","key":"6297_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22037\/jpn.v7i2.25546","volume":"7","author":"Y Ravanshad","year":"2019","unstructured":"Ravanshad Y, Azarfar A, Esmaeeli M et al (2019) Clinical effects of methylphenidate compared to oxybutynin on management of giggle incontinence. J Pediatr Nephrol 7(2):1\u20133. https:\/\/doi.org\/10.22037\/jpn.v7i2.25546","journal-title":"J Pediatr Nephrol"},{"issue":"7","key":"6297_CR19","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/nau.25232","volume":"42","author":"AM Svendsen","year":"2023","unstructured":"Svendsen AM, Kamperis K, Hagstroem S, Thorsteinsson KN, Arvad M, Borch L (2023) The effect of methylphenidate for giggle incontinence in children. Neurourol Urodyn 42(7):1470\u20131475. https:\/\/doi.org\/10.1002\/nau.25232","journal-title":"Neurourol Urodyn"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-026-06297-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-026-06297-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:26:45Z","timestamp":1781634405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-026-06297-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6297"],"URL":"https:\/\/doi.org\/10.1007\/s00383-026-06297-7","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"of interest: none.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"103"}}